To further verify whether TP5 promotes the antitumor effect of OXA by inhibiting colon cancer stem cells, we measured the expression of cancer stem cell markers CD24 and CD44 by flow cytometry after TP5 and OXA were co-administered to colon cancer HCT116 cells for 24 h. The gene discussed is CD24; the disease is malignant colon neoplasm.